摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)methanol | 25634-94-0

中文名称
——
中文别名
——
英文名称
(1-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)methanol
英文别名
1-Hydroxymethyl-1-methyl-tetralin;(1-methyl-3,4-dihydro-2H-naphthalen-1-yl)methanol
(1-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)methanol化学式
CAS
25634-94-0
化学式
C12H16O
mdl
——
分子量
176.258
InChiKey
BVOXKRPQUJYDDZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)methanolchromium(VI) oxide叔丁基过氧化氢草酰氯potassium carbonate二甲基亚砜 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 20.0h, 生成 4-ethynyl-4-methyl-3,4-dihydronaphthalen-1(2H)-one
    参考文献:
    名称:
    New Monocyclic, Bicyclic, and Tricyclic Ethynylcyanodienones as Activators of the Keap1/Nrf2/ARE Pathway and Inhibitors of Inducible Nitric Oxide Synthase
    摘要:
    A monocyclic compound 3 (3-ethynyl-3-methyl-6-oxocyclohexa-1,4-dienecarbonitrile) is a highly reactive Michael acceptor leading to reversible adducts with nucleophiles, which displays equal or greater potency than the pentacyclic triterpenoid CDDO in inflammation and carcinogenesis related assays. Recently, reversible covalent drugs, which bind with protein targets but not permanently, have been gaining attention because of their unique features. To explore such reversible covalent drugs, we have synthesized monocyclic, bicyclic, and tricyclic compounds containing 3 as an electrophilic fragment and evaluated them as activators of the Keap1/Nrf2/ARE pathway and inhibitors of iNOS. Notably, these compounds maintain the unique features of the chemical reactivity and biological potency of 3. Among them, a monocyclic compound 5 is the most potent in these assays while a tricyclic compound 14 displays a more robust and specific activation profile compared to 5. In conclusion, we demonstrate that 3 is a useful electrophilic fragment for exploring reversible covalent drugs.
    DOI:
    10.1021/acs.jmedchem.5b00393
  • 作为产物:
    描述:
    1,2,3,4,-四氢-1-萘甲酸甲酯 在 lithium aluminium tetrahydride 、 lithium diisopropyl amide 作用下, 以 四氢呋喃 为溶剂, 反应 21.67h, 生成 (1-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)methanol
    参考文献:
    名称:
    New Monocyclic, Bicyclic, and Tricyclic Ethynylcyanodienones as Activators of the Keap1/Nrf2/ARE Pathway and Inhibitors of Inducible Nitric Oxide Synthase
    摘要:
    A monocyclic compound 3 (3-ethynyl-3-methyl-6-oxocyclohexa-1,4-dienecarbonitrile) is a highly reactive Michael acceptor leading to reversible adducts with nucleophiles, which displays equal or greater potency than the pentacyclic triterpenoid CDDO in inflammation and carcinogenesis related assays. Recently, reversible covalent drugs, which bind with protein targets but not permanently, have been gaining attention because of their unique features. To explore such reversible covalent drugs, we have synthesized monocyclic, bicyclic, and tricyclic compounds containing 3 as an electrophilic fragment and evaluated them as activators of the Keap1/Nrf2/ARE pathway and inhibitors of iNOS. Notably, these compounds maintain the unique features of the chemical reactivity and biological potency of 3. Among them, a monocyclic compound 5 is the most potent in these assays while a tricyclic compound 14 displays a more robust and specific activation profile compared to 5. In conclusion, we demonstrate that 3 is a useful electrophilic fragment for exploring reversible covalent drugs.
    DOI:
    10.1021/acs.jmedchem.5b00393
点击查看最新优质反应信息

文献信息

  • Synthesis and biological activity of both enantiomers of kujigamberol isolated from 85-million-years-old Kuji amber
    作者:Yue Qi Ye、Hiroyuki Koshino、Daisuke Hashizume、Yuki Minamikawa、Ken-ichi Kimura、Shunya Takahashi
    DOI:10.1016/j.bmcl.2012.05.022
    日期:2012.7
    and (3) optical resolution of (±)-1 using chromatographical separation of the corresponding camphanates. X-ray crystallographical analysis of p-bromobenzoate obtained from the more polar camphanate that was identical with a natural derivative, revealed natural kujigamberol to have an S-configuration. Both the natural enantiomer and its (R)-antipode showed the same inhibitory activity toward the mutant
    通过全合成确定降冰片烷萜类化合物,苦瓜糖醇(1)的完整结构。总合成的关键特征是(1)通过苯甲酰胺的邻位化来安装异戊基;(2)通过RCM反应构建四氢萘酮;(3)使用色谱分离法测定(±)-1的光学拆分度。相应的樟脑。从极性更大的樟脑酸酯获得的对-溴苯甲酸酯的X射线晶体学分析与天然衍生物相同,表明天然的苦瓜酚具有S-构型。天然对映体及其(R)-对映体对突变酵母和HL - 60细胞具有相同的抑制活性,而在C-8和(±)-1的9位上没有烷基的简单类似物则没有这种活性。
  • Access to Benzylic Quaternary Carbons from Aromatic Ketones
    作者:You Li、Jingpeng Han、Han Luo、Qiaoyu An、Xiao-Ping Cao、Baosheng Li
    DOI:10.1021/acs.orglett.9b02204
    日期:2019.8.2
    constructing all-carbon quaternary structural units from aryl ketones, revealing that the entire process involves three consecutive chemical events, namely nucleophilic addition, Meinwald 1,2-hydrogen migration, and alkylation. Interestingly, dimerization of acetophenones results in formation of 2,4-diarylfurans under the employed conditions rather than the quaternary carbon products.
    在生物分子和药物中普遍存在的苄基全碳四元立体中心的构建是具有高度实际意义的任务。在这里,我们公开了一种由芳基酮构建全碳四元结构单元的高效一锅法,揭示了整个过程涉及三个连续的化学事件,即亲核加成,Meinwald 1,2-氢迁移和烷基化。有趣的是,在所采用的条件下,苯乙酮的二聚作用导致形成2,4-二芳基呋喃,而不是季碳产物。
  • Acetylenic cyanoenones as therapeutics for inflammation and carcinogenesis
    申请人:Honda Tadashi
    公开号:US10233146B2
    公开(公告)日:2019-03-19
    The present invention provides a compound having the structure: wherein X is C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, cyano, aryl, heteroaryl, alkylaryl, alkylheteroaryl, alkenylaryl, alkenylheteroaryl, alkynylaryl, alkynylheteroaryl, alkoxy, alkenyloxy, alkynyloxy, aryloxy, heteroaryloxy, acyl, alkylhydroxy, alkylamino, alkenylamino, alkynylamino, amido, carboxyl, or carboxyl ester, or forms an unsubstituted or substituted cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, indane or tetralin with Y, Y is H or forms an unsubstituted or substituted cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, indane or tetralin with X, or forms an unsubstituted or substituted monocycle with Z; and Z is H or forms an unsubstituted or substituted monocycle with Y; wherein when X and Y are both H, then X is C2 alkenyl or C2 alkynyl, and when Y is H forms a substituted cyclohexyl, cycloheptyl with X, the cyclohexyl is other than a trisubstituted cyclohexyl bearing CH3, i-Pr and (CH2)2CO2CH3 groups or CH3, i-Pr and (CH2)3NH2, or a salt or ester thereof.
    本发明提供了一种具有以下结构的化合物: 其中 X是C1-C12烷基、C2-C12烯基、C2-C12炔基、氰基、芳基、杂芳基、烷芳基、烷基异芳基、烯芳基、烯基异芳基、炔芳基、炔基异芳基、烷氧基、烯氧基、炔氧基、芳氧基、杂芳氧基、酰基、烷基羟基、烷基氨基、烯基氨基、炔基氨基、氨基、羧基或羧基酯,或与 Y 形成未取代或取代的环丁基、环戊基、环己基、环庚基、茚或四萘、 Y 是 H,或与 X 形成未取代或取代的环丁基、环戊基、环己基、环庚基、茚满或四萘,或与 Z 形成未取代或取代的单环;和 Z 是 H,或与 Y 形成未取代或取代的单环; 其中,当 X 和 Y 均为 H 时,则 X 为 C2 烯基或 C2 炔基,而当 Y 为 H 时,则与 X 形成取代的环己基、环庚基,该环己基是三取代的环己基以外的环己基。 当 Y 为 H 与 X 形成取代的环己基、环庚基时,环己基不是含有 CH3、i-Pr 和 (CH2)2CO2CH3 基团或 CH3、i-Pr 和 (CH2)3NH2 的三取代环己基、 或其盐或酯。
  • Julia,M.; Labia,R., Bulletin de la Societe Chimique de France, 1972, p. 4151 - 4157
    作者:Julia,M.、Labia,R.
    DOI:——
    日期:——
  • Julia,M.; Mansuy,D., Bulletin de la Societe Chimique de France, 1972, p. 2684 - 2689
    作者:Julia,M.、Mansuy,D.
    DOI:——
    日期:——
查看更多

同类化合物

(S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 顺式-4-(4-氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐 顺式-4-(3,4-二氯苯基)-1,2,3,4-四氢N-叔丁氧羰基-1-萘胺 顺式-1-苯甲酰氧基-2-二甲基氨基-1,2,3,4-四氢萘 顺式-1,2,3,4-四氢-5-环氧丙氧基-2,3-萘二醇 顺式-(1S,4S)-N-甲基-4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺扁桃酸盐 顺-5,6,7,8-四氢-6,7-二羟基-1-萘酚 顺-(+)-5-甲氧基-1-甲基-2-(二正丙基氨基)萘满马来酸 阿洛米酮 阿戈美拉汀杂质醇(A) 阿戈美拉汀杂质 钠2-羟基-7-甲氧基-1,2,3,4-四氢-2-萘磺酸酯 金钟醇 邻烯丙基苯基溴化镁 那高利特盐酸盐 那高利特 过氧化,1,1-二甲基乙基1,2,3,4-四氢-1-萘基 贝多拉君 螺<4.7>十二烷 蔡醇酮 萘磺酸,二癸基-1,2,3,4-四氢- 萘并[2,3-d]咪唑,2-乙基-5,6,7,8-四氢-(6CI) 萘亚胺 苯甲酸-(5,6,7,8-四氢-[2]萘基酯) 苯甲丁氮酮 苯甲丁氮酮 苯甲丁氮酮 苯并烯氟菌唑 舍曲林二甲基杂质盐酸盐 舍曲林EP杂质B 舍曲林 羟甲基四氢萘酚 美曲唑啉 罗替戈汀硫酸盐 罗替戈汀杂质18 罗替戈汀中间体 罗替戈汀中间体 罗替戈汀 罗替戈汀 纳多洛尔杂质 米贝地尔(二盐酸盐) 盐酸舍曲林 盐酸舍曲林 盐酸罗替戈汀 盐酸左布诺洛尔 盐酸四氢唑林 甲基缩合物 甲基6-[1-(3,5,5,8,8-五甲基-5,6,7,8-四氢-2-萘基)环丙基]烟酸酯 甲基-(2-吡咯烷-1-基甲基-1,2,3,4-四氢-萘-2-基)-胺 环丙烯并[a]茚,1-溴-1-氟-1,1a,6,6a-四氢-